Tecentriq is a chemotherapy drug indicated for the treatment of urothelial carcinoma, which is a type of bladder cancer, especially in advanced or metastatic cases, without improvement with other types of treatment.
The active principle of this medicine is Atezolizumab, a new monoclonal antibody-type drug that acts directly on the immune system to stimulate the body in fighting cancer. This medicine is not yet produced in Brazil, although ANVISA allows its importation from the United States in specific cases and with a justified medical indication.
Price and how to buy
Although it is not manufactured or commercialized in Brazil, Tecentriq can be imported by some pharmacies, which can sell this medicine at the price that costs, in average, R $ 75.000, 00 per vial ampoule 1200mg / 20ml.
How to use
Atezolizumab is a medicinal product that should be used through intravenous infusions according to the medical indication, usually 1200mg diluted in saline for 60 minutes in doses every 3 weeks.
The number of doses and the time of treatment should be indicated by the oncologist, according to the clinical picture of each patient.
Possible side effects
The most common side effects of Atezolizumab include tiredness, reduced appetite, urinary tract infection, fever, nausea and constipation.
It is important to tell your doctor if new or intense symptoms develop, as this medicine may cause severe immune reactions such as pneumonitis, nephritis, hepatitis, or colitis.
Who should not use
There are no formal contraindications reported, however, it is important that the physician carefully monitor and use them with caution in cases of immune reactions such as hepatitis, pneumonitis, colitis, diabetes, pancreatitis or infections, for example, temporary in these cases.
It should also be avoided in case of allergies to formula components, gestation or breastfeeding.
